英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：


请选择你想看的字典辞典：
单词字典翻译
assertio查看　assertio　在百度字典中的解释百度英翻中〔查看〕
assertio查看　assertio　在Google字典中的解释Google英翻中〔查看〕
assertio查看　assertio　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • Assertio Holdings
    March 3, 2026 Assertio Holdings, Inc to Report Fourth Quarter and Full Year 2025 Financial Results on March 16, 2026 More News
  • Assertio Holdings, Inc. - Investor Relations
    Corporate Overview Assertio is a leading commercial pharmaceutical company bringing differentiated products to patients and has a robust portfolio of branded prescription products in neurology, oncology, hospital and pain and inflammation The Company has grown through business development including licensing, mergers, and acquisitions and is interested in products across all therapeutic areas
  • Assertio Holdings » Overview
    Welcome to Assertio We are a leading commercial pharmaceutical company bringing differentiated products to patients We have a robust portfolio of branded prescription neurology, inflammation, pain and oncology medications The company has grown through business development including acquisitions, licensing and mergers
  • Assertio Holdings, Inc. - News
    Download , Assertio Holdings, Inc to Report Fourth Quarter and Full Year 2025 Financial Results on March 16, 2026, 03 03 2026, (opens in new window)
  • Assertio Holdings » Products
    To answer patient or healthcare provider questions regarding Assertio products including Customer Service, Product Information or Adverse Event Reporting, contact us at 800-518-1084 or medinfo@assertiotx com
  • Assertio Holdings » Management
    He oversees Assertio’s medical and clinical scientific leadership for development programs, product assessments and life cycle management Dr Franklin was previously Chief Medical Officer at Finch Therapeutics, a microbiome-based biotechnology firm applying new technologies to the treatment of immuno-oncology, IBD and autism spectrum disorder
  • Assertio Holdings, Inc. - Financials - Quarterly Results
    LAKE FOREST, Ill-- (BUSINESS WIRE)-- Assertio Holdings, Inc (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities offering differentiated products designed to address patients’ needs, today reported financial results for the fourth quarter and full year ended December 31, 2025
  • Assertio Holdings, Inc. - Financials - Annual Reports
    At Assertio Holdings, Inc we promise to treat your data with respect and will not share your information with any third party You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below
  • Assertio Holdings, Inc. - Events Presentations
    Assertio Holdings September 2025 Overview Download PDF 09 09 2025 Assertio Holdings Fact Sheet September 2025 Download PDF
  • Assertio Holdings » Business Development
    Assertio’s strategic goals involve in-licensing and acquiring assets to build on our current areas and expand into other specialty areas In collaborating with our partners, we aim to benefit both parties while building a portfolio that addresses the needs of patients, physicians and payers alike





中文字典-英文字典  2005-2009